Following the development for liquid biopsies of the SiRe next-generation sequencing (NGS) panel that covers 568 clinical relevant mutations in EGFR, KRAS, NRAS, BRAF, cKIT and PDGFRa genes, in this current study, we apply this small NGS panel on tissue samples of lung cancer.

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

Pepe, Francesco;De Luca, Caterina;Smeraglio, Riccardo;Pisapia, Pasquale;Sgariglia, Roberta;Nacchio, Mariantonia;Russo, Maria;Serra, Nicola;Gragnano, Gianluca;Vigliar, Elena;Bellevicine, Claudio;Troncone, Giancarlo;Malapelle, Umberto
2019

Abstract

Following the development for liquid biopsies of the SiRe next-generation sequencing (NGS) panel that covers 568 clinical relevant mutations in EGFR, KRAS, NRAS, BRAF, cKIT and PDGFRa genes, in this current study, we apply this small NGS panel on tissue samples of lung cancer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11588/727297
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 25
social impact